Xenetic Biosciences Inc (XBIO): Slowly stair stepping up- nice ans stead...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	30
Posts	4823
Boards Moderated	0
Alias Born	01/21/2009

Brian903

Re: None

Thursday, 09/12/2019 4:54:00 PM

Thursday, September 12, 2019 4:54:00 PM

Slowly stair stepping up- nice ans steady filling the gaps. Waiting on announcement of Takeda Licensing Revenue!

Strong contender for a run to 2.00++++

Shorts are out- buyers are in

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent XBIO News

Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:15:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 10:18:54 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 10:16:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:30:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:30:18 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:30:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:30:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:00:32 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/13/2023 10:00:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:30:10 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:00:42 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/18/2023 04:21:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 12:05:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:30:48 PM

More XBIO News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover